Sept. 2, 2003 (Vienna) -- Ivabradine, an investigational agent that is the first of a new class of drugs called I f inhibitors, is as effective and safe as atenolol for the treatment of stable angina, ...

The therapeutic profile of olmesartan medoxomil, which is a recently developed angiotensin II (A II) receptor blocker, has been compared with four commonly used antihypertensive therapeutic drugs ...

Please provide your email address to receive an email when new articles are posted on . Long-term results from the ASCOT trial demonstrated that an amlodipine-based BP-lowering regimen reduced stroke ...

Alternatively, the positive effects on glucose and lipid metabolism of centrally acting drugs – agonists of imidazoline receptors were shown. 9 Although the long-term outcome of negative metabolic ...